Simon He

Simon Simon has a diverse work experience in finance and accounting spanning nearly three decades. Simon has held various leadership positions in well-established organizations such as CytomX Therapeutics, BlackThorn Therapeutics, GenapSys, Inc., SciClone Pharmaceuticals, Baidu leho.com, umessage, Dell, Ecolab, Unilever, and PwC.

Their recent experience includes working as the Director of Financial Planning & Analysis at CytomX Therapeutics. Prior to that, they served as the Associate Director of Financial Planning & Analysis at the same company. At BlackThorn Therapeutics, they served as the Director of Finance, where they drove budget vs actual analysis, managed cash flow analysis, and led the implementation of NetSuite ERP.

As the Head of Finance/Controller at GenapSys, Inc., they supported capital raising efforts through financial modeling and budgeting. Additionally, they worked as the Director of Finance at SciClone Pharmaceuticals, managing financial budgeting, consolidation, and reporting, as well as leading financial system transformation.

During their tenure at Baidu leho.com, they held the position of Vice President of Finance and was responsible for establishing financial accounting infrastructure and developing financial planning and analysis processes. Prior to that, at umessage, they worked as the Vice President of Finance, overseeing the company's IPO process and enhancing financial reporting and control processes.

Simon also has experience as a Finance Manager at Dell, a Senior Financial Analyst at Ecolab, a Senior Finance Manager/Senior Corporate Auditor at Unilever, and a Senior Auditor at PwC.

Overall, Simon He's work experience showcases their expertise in financial planning and analysis, financial reporting, budget management, and financial system implementation. Simon has a proven track record of supporting business decision-making through sound financial advice and guidance.

Simon Simon has a Master of Business Administration degree in Finance and Strategy from The University of Chicago Booth School of Business, which they completed in 2006. Prior to that, they obtained a Bachelor of Science degree in Accounting from Beijing University of Technology. In terms of additional certifications, they have completed a course in Drug Development Product Management at UC San Diego in February 2022 and obtained a Certified Management Accountant (CMA) certification from IMA | Institute of Management Accountants in 2002.